ABSTRACT
PURPOSE: To test the agreement and correlation between the frequency doubling technology and the short wavelength perimetry in glaucoma. METHODS: Glaucoma patients were selected from the Glaucoma Sector of CEROF - Universidade Federal de Goiás, and then underwent frequency doubling technology and short wavelength perimetry examinations in both eyes (if eligible) on the same day in a random sequence. Pearson's correlation between the global indices (mean deviation - MD e pattern standard deviation - PSD) and the agreement between the examinations (Kappa) were obtained. RESULTS: Forty-three eyes from 26 patients were included in the study. Comparing the MD (-4.5 +/- 4.5 dB for the frequency doubling technology and -8.0 +/-6.8 dB for the short wavelength perimetry, p<0.001) and PSD (6.4 +/- 2.8 dB for the FDT and 5.8 +/- 2.4 dB for SWAP, p=0.1), only MD was statistically different between the groups. The global indices MD e PSD were highly correlated between the frequency doubling technology and short wavelength perimetry (r=0.644, p<0.001 and r=0.586, p<0.001, respectively). There was a high agreement between the examinations (Kappa=0.319, p<0.001). CONCLUSION: In the present study, a high correlation between the global indices (MD and PSD) by the frequency doubling technology and short wavelength perimetry was found, as well as a high agreement between the examinations. These observations indicate either that both cell populations are similarly affected by glaucomatous damage or that both methods measure activity in the same cell populations.
Subject(s)
Glaucoma/diagnosis , Visual Field Tests/methods , Female , Humans , Male , Middle Aged , Reproducibility of Results , Severity of Illness IndexABSTRACT
OBJETIVO: Avaliar a concordância e correlação entre a perimetria de freqüência dupla e a perimetria azul-amarelo no glaucoma. MÉTODOS: Pacientes com glaucoma foram selecionados do Setor de Glaucoma do Centro de Referência em Oftalmologia (CEROF) da Universidade Federal de Goiás, e submetidos aos exames de perimetria de freqüência dupla e perimetria azul-amarelo em ambos os olhos (quando elegíveis) no mesmo dia de maneira aleatória. Foi obtido a correlação (Pearson) entre os índices globais (mean deviation - MD e pattern standard deviation - PSD) e a concordância entre os exames (índice Kappa) para a gravidade do dano glaucomatoso. RESULTADOS: Quarenta e três olhos de 26 pacientes foram incluídos no estudo. Comparando-se o MD (-4,5±4,5 dB para o perimetria de freqüência dupla e -8,0±6,8 dB para o perimetria azul-amarelo, p<0,001) e o PSD (6,4±2,8 dB para o perimetria de freqüência dupla e 5,8±2,4 dB para o perimetria azul-amarelo, p=0,1), verificamos que apenas o MD mostrou diferença estatisticamente significativa entre os grupos. Os índices globais MD e PSD foram altamente correlacionados comparando-se o perimetria de freqüência dupla e o perimetria azul-amarelo (r=0,644, p<0,001 e r=0,586, p<0,001, respectivamente). A concordância entre as classificações da gravidade da perda glaucomatosa mostrou-se significativa (Kappa=0,319, p<0,001). CONCLUSÃO: Existe alta correlação entre os índices globais e alta concordância em termos de classificação da gravidade do dano glaucomatoso entre a perimetria azul-amarelo e a perimetria de freqüência dupla, refletindo ausência de seletividade no dano glaucomatoso, ou que os instrumentos disponíveis não sejam capazes de isolar as células ganglionares de forma completa.
PURPOSE: To test the agreement and correlation between the frequency doubling technology and the short wavelength perimetry in glaucoma. METHODS: Glaucoma patients were selected from the Glaucoma Sector of CEROF - Universidade Federal de Goiás, and then underwent frequency doubling technology and short wavelength perimetry examinations in both eyes (if eligible) on the same day in a random sequence. Pearson's correlation between the global indices (mean deviation - MD e pattern standard deviation - PSD) and the agreement between the examinations (Kappa) were obtained. RESULTS: Forty-three eyes from 26 patients were included in the study. Comparing the MD (-4.5±4.5 dB for the frequency doubling technology and -8.0±6.8 dB for the short wavelength perimetry, p<0.001) and PSD (6.4±2.8 dB for the FDT and 5.8±2.4 dB for SWAP, p=0.1), only MD was statistically different between the groups. The global indices MD e PSD were highly correlated between the frequency doubling technology and short wavelength perimetry (r=0.644, p<0.001 and r=0.586, p<0.001, respectively). There was a high agreement between the examinations (Kappa=0.319, p<0.001). CONCLUSION: In the present study, a high correlation between the global indices (MD and PSD) by the frequency doubling technology and short wavelength perimetry was found, as well as a high agreement between the examinations. These observations indicate either that both cell populations are similarly affected by glaucomatous damage or that both methods measure activity in the same cell populations.
Subject(s)
Female , Humans , Male , Middle Aged , Glaucoma/diagnosis , Visual Field Tests , Reproducibility of Results , Severity of Illness IndexABSTRACT
PURPOSE: To evaluate the ibopamine provocative test for the diagnosis of glaucoma in glaucoma patients using antiglaucomatous drugs. METHODS: Two 2% ibopamine eyedrops were instilled 5 minutes apart in one eye selected at random in both glaucoma and normal subjects. The intraocular pressure (IOP) was assessed prior to the drops and 30, 60 and 180 minutes after instillation. The test was considered positive when there was an intraocular pressure increase of greater than 4 mmHg at any one of the time-points. The amount of intraocular pressure change was compared to the types of medical treatment. RESULTS: Fifty-eight eyes were included (38 glaucoma patients and 20 normal individuals). The intraocular pressure rise was significantly higher in glaucoma patients (p<0.001 at all times). The sensitivity and specificity of the ibopamine test were 68% (87% if we exclude eyes using prostaglandin analogues) and 95%, respectively. Glaucoma patients using prostaglandin analogues did not present a significant intraocular pressure elevation. CONCLUSION: The ibopamine provocative test may be an auxiliary test in glaucoma diagnosis. Despite the small sample size, concurrent use of prostaglandin analogues apparently reduces the test's sensitivity.
Subject(s)
Deoxyepinephrine/analogs & derivatives , Dopamine Agonists , Glaucoma/diagnosis , Intraocular Pressure/drug effects , Prostaglandins, Synthetic/therapeutic use , Tonometry, Ocular , Deoxyepinephrine/administration & dosage , Glaucoma/drug therapy , Humans , Sensitivity and Specificity , Time FactorsABSTRACT
OBJETIVO: Avaliar o desempenho do teste provocativo da ibopamina em pacientes com glaucoma usuários de drogas hipotensoras. MÉTODOS: Pacientes glaucomatosos foram recrutados do Centro de Referência em Oftalmologia (CEROF) da Universidade Federal de Goiás, e suas drogas hipotensoras em uso registradas. Indivíduos normais foram amigos e parentes dos pacientes. A seguir, foram instiladas duas gotas de ibopamina 2 por cento com intervalo de 5 minutos. A pressão intra-ocular (Pio) foi medida previamente, e após 30, 60 e 180 minutos. No nosso estudo, o teste da ibopamina foi considerado positivo quando a pressão intra-ocular excedeu 4 mmHg em pelo menos uma das medidas. RESULTADOS: Cinquenta e oito olhos de 58 indivíduos (38 glaucomatosos e 20 normais) foram incluídos no estudo. O aumento da pressão intra-ocular foi maior nos pacientes com glaucoma aos 30, 60 e 180 minutos (p<0,001 em todas as ocasiões). O aumento da pressão intra-ocular foi estatisticamente maior aos 30 minutos nos indivíduos que não utilizavam análogos das prostaglandinas (p=0,01). A sensibilidade do teste foi de 68 por cento (87 por cento se excluirmos pacientes em uso de análogos das prostaglandinas), e a especificidade de 95 por cento. CONCLUSÃO: O teste provocativo da ibopamina 2 por cento pode ser ferramenta auxiliar no diagnóstico do glaucoma. Apesar da pequena amostra estudada, sugere-se que olhos em uso de análogos das prostaglandinas têm reduzido a sensibilidade do mesmo.
Subject(s)
Humans , Deoxyepinephrine/analogs & derivatives , Dopamine Agonists , Glaucoma/diagnosis , Intraocular Pressure/drug effects , Prostaglandins, Synthetic/therapeutic use , Tonometry, Ocular , Deoxyepinephrine/administration & dosage , Deoxyepinephrine , Glaucoma/drug therapy , Sensitivity and Specificity , Time FactorsABSTRACT
PURPOSE: To verify the influence of modality of treatment in regions of the glaucomatous visual field after reduction of intraocular pressure (IOP). METHODS: Glaucoma patients that had undergone a reduction of IOP of at least 20% in a period of 2 months were retrospectively selected and divided into 2 groups: 1) after trabeculectomy; 2) after clinical treatment. Visual field global indices and thresholds (average, divided according to the severity based on the Pattern Deviation plot) were compared before and after IOP reduction. RESULTS: Thirty-one eyes of 22 patients were selected (15 in group 1, and 16 in group 2). Both groups showed good ability regarding improvement of different regions of the visual field after IOP reduction. Only the percentage of reduction of IOP (52.3+/-18.9% and 37.8+/-15.2% for groups 1 and 2, respectively, p=0.02) and the percentage of improvement in the points damaged at p<0.5% (186.0+/-213.3% and 30.1+/-35.2% for groups 1 and 2, respectively, p=0.02) were different, but not statistically significant after alpha error correction between groups. CONCLUSION: The reduction of IOP above 20% may be associated with improvement in regions of the glaucomatous visual field, regardless of treatment modality.
Subject(s)
Glaucoma, Open-Angle , Intraocular Pressure/physiology , Ocular Hypertension , Visual Fields/physiology , Aged , Glaucoma, Open-Angle/drug therapy , Glaucoma, Open-Angle/physiopathology , Glaucoma, Open-Angle/surgery , Humans , Middle Aged , Ocular Hypertension/drug therapy , Ocular Hypertension/physiopathology , Ocular Hypertension/surgery , Retrospective Studies , Tonometry, Ocular , TrabeculectomyABSTRACT
OBJETIVO: Comparar a influência do tipo de tratamento em diferentes regiões do campo visual glaucomatoso após reducão da pressão intra-ocular (Pio). MÉTODOS: Pacientes com glaucoma que obtiveram reducão da Pio de pelo menos 20 por cento em um período de 2 meses foram retrospectivamente selecionados e divididos em 2 grupos: 1) após trabeculectomia; 2) após tratamento clínico. índices do campo visual e os limiares de sensibilidade (totais, e divididos de acordo com a gravidade no gráfico do "Pattern Deviation") foram anotados imediatamente antes e após a reducão da Pio, comparados entre os grupos, e dentro dos mesmos. RESULTADOS: Trinta e um olhos de 22 pacientes foram incluídos no estudo (15 no grupo 1, e 16 no grupo 2). Ambos os grupos demonstraram alta habilidade na melhora de regiões do campo visual após a reducão da Pio. Apenas a porcentagem da reducão da Pio (52,3n18,9 por cento e 37,8n15,2 por cento para os grupos 1 e 2, respectivamente, p=0,02) e a porcentagem de melhora nos pontos lesados a 0,5 por cento (186,0n213,3 por cento e 30,1n35,2 por cento para os grupos 1 e 2, respectivamente, p=0,02) foram diferentes entre os grupos, porém sem significância após correcão do erro alfa. CONCLUSAO: A reducão da Pio acima de 20 por cento pode estar associada à melhora em regiões do campo visual glaucomatoso, independente da modalidade de tratamento.
Subject(s)
Humans , Glaucoma, Open-Angle/physiopathology , Intraocular Pressure/physiology , Ocular Hypertension/physiopathology , Visual Fields/physiology , Glaucoma, Open-Angle/drug therapy , Glaucoma, Open-Angle/surgery , Ocular Hypertension/drug therapy , Ocular Hypertension/surgery , Retrospective Studies , Tonometry, Ocular , TrabeculectomyABSTRACT
PURPOSE: To verify the quality of life in a Brazilian glaucoma population and the influence of possible modifiers (e.g., visual acuity, visual field impairment). METHODS: Forty-five consecutive patients from CEROF - Federal University of Goias, Brazil were included prospectively in the study. The quality of life was assessed using the Portuguese version of the VFQ. Possible modifiers were evaluated, initially separately with the Spearman's Correlation and then together in a regression model. RESULTS: The mean age was 59.6 +/- 12.4 years. The mean quality of life score was 79 +/- 15 (range 45-100). Age (r = -0.402, p = 0.006), visual acuity in the better eye (r = -0.497, p = 0.001) and in the worse eye (r = -0.608, p < 0.001), Hodapp-Parrish-Anderson visual field grading scale in the better (r = -0.353, p = 0.01) and worse eye (r = -0.387, p = 0.009), visual field Mean Deviation (MD) in the better (r = 0.355, p = 0.01) and worse eye (r = 0.320, p = 0.04) and ability to perform a visual field test in both eyes (r = -0.397, p = 0.007) were significantly correlated with the quality of life scores. However, only age (younger, better quality of life, p = 0.008) and visual acuity in the better eye (direct relation, p = 0.04) were significant in the regression model (r = 0.633, r(2) = 0.401). CONCLUSIONS: The VFQ may be a useful tool to assess the quality of life in glaucoma patients. The preliminary results indicate that age and visual acuity in the better eye are the main factors related to the quality of life in these patients.
